| 2013 | |
| Gilles AVENARD | |
Chargement de la carte ... |
|
| 5 | |
| 4 | |
| Non cotée | |
| 0 M€ | |
| 2 M€ | |
| 0.9 M€ | |
| 3 M€ | |
| https://acticor-biotech.com/ | |
| Acticor Biotech is a clinical stage biotech company, developing an innovative drug for the treatment of acute thrombotic diseases, including the acute phase of ischemic stroke. Acticor Biotech is a spin-off company from Inserm (French National Institute of Health and Medical Research) founded in November 2013. |
Fiche créée le 30/06/2021 par C Chloay vue 3 fois.